Table 1

Preclinical study characteristics

IDPublicationDrugSpeciesnDose (duration)Motor scoreInjury levelFollow-upType of injuryApplication
1Redondo-Castro, EIbuRats1660 mg/kg/day (42 days)BBBT842 daysContusionSubcutaneous
2Sharp, KIbuRats7360 mg/kg/day (28 days)BBBT6/742 daysHemisectionSubcutaneous
3Wang, XIbuMice4635–70 mg/kg/day (28 days)BMST835 daysTransectionSubcutaneous
4Guth, LIndoRats120.2 mg/day (21 days)TarlovT821 daysCompressionIntraperitoneal
5Wang, XIbuRats4770 mg/kg/day (28 days)BBBT749 daysContusionSubcutaneous
6
7
Fu, QIbuRats19
12
60 mg/kg/day (28 days)
60 mg/kg/day (28 days)
BBBT6/742 daysHemisectionSubcutaneous
Contusion
8
9
10
11
Pantovic, RIndoRabbits6
6
6
6
6
0.1 mg/kg/day (9 days)
0.3 mg/kg/day (9 days)
1.0 mg/kg/day (9 days)
3.0 mg/kg/day (9 days)
vehicle
TarlovL29 daysContusionIntravenous
  • BBB, Basso, Beattie and Bresnahan; BMS, Basso Mouse Scale; Ibu, ibuprofen; Indo, indometacin; n, number of animals.